Table 3.
Comparison of RRT modalities within registries in children*
| Registry (number of countries) | Age (years) | Initial treatment modality (%) | Prevalent treatment modality (%) | ||||
|---|---|---|---|---|---|---|---|
| HD | PD | Transplantation | HD | PD | Transplantation | ||
| ANZDATA (2) | 0–19 | 45 | 39 | 16 | 12 | 15 | 73 |
| ERA-EDTA (11) | 0–19 | 44 | 35 | 21 | 13 | 7 | 80 |
| ESPN/ERA-EDTA (31) | 0–14 | 36 | 49 | 15 | 14 | 21 | 65 |
| USRDS (1) | 0–19 | 52 | 31 | 17 | 17 | 11 | 71 |
| 0–14 | 35 | 46 | 19 | 15 | 11 | 74 | |
| CORR/Canada (1) | 0–19 | 52 | 30 | 18 | 9 | 13 | 78 |
| Japan (1) | 0–18 | 30 | 69 | 1 | 17 | 42 | 41 |
USRDS, US Renal Data System; CORR, Canadian Organ Replacement Register
*Prevalence at 31 December 2008, except data from Japan at 1 January 1998, incidence reported from data in 2008 (ESPN/ERA-EDTA and USRDS), 2003–2008 (ANZDATA), 2007–2008 (ERA-EDTA), 2007–2009 (CORR), and 1998 (Japan)